About Epilepsy

At Arvelle, we are committed to helping those affected by epilepsy. We aspire to do this by making innovative therapies available to more patients.

About Epilepsy

International Epilepsy Day

Join Arvelle and help promote the “50 Million Steps for Epilepsy” campaign

Find out more

Media

Press Releases and Events

View all

New study demonstrates the safety and tolerability of treatment with cenobamate tablets in adults with focal seizures

Angelini Pharma finalizes the acquisition agreement

ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults*

Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments